CIPROFOLXACIN

CIPROFOLXACIN was reported 71987 times

CIPROFOLXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 96 0.3168
1 TENDON DISCOMFORT 230 0.3046
2 GEOTRICHUM INFECTION 56 0.2654
3 TENDON PAIN 1663 0.2194
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 163 0.1535
5 HYPERPARATHYROIDISM SECONDARY 352 0.1404
6 DYSBIOSIS 115 0.1401
7 NEPHROGENIC ANAEMIA 648 0.1397
8 TENDON DISORDER 852 0.1305
9 REBOUND ACID HYPERSECRETION 384 0.1268
10 NASAL OEDEMA 215 0.1189
11 CRYSTAL NEPHROPATHY 69 0.1166
12 TENDONITIS 1775 0.1145
13 SMALL FIBRE NEUROPATHY 79 0.1070
14 JOINT NOISE 174 0.0885
15 FEMALE GENITAL TRACT FISTULA 137 0.0802
16 CHRONIC FATIGUE SYNDROME 109 0.0782
17 JOINT CREPITATION 155 0.0781
18 TENDON RUPTURE 901 0.0729
19 CONNECTIVE TISSUE DISORDER 101 0.0711
20 TENDON INJURY 257 0.0690
21 POUCHITIS 59 0.0685
22 END STAGE RENAL DISEASE 1243 0.0681
23 EPICONDYLITIS 99 0.0656
24 PSEUDOMEMBRANOUS COLITIS 132 0.0591
25 VANISHING BILE DUCT SYNDROME 61 0.0547
26 MUSCLE RUPTURE 205 0.0526
27 RADICULOPATHY 138 0.0523
28 CHRONIC KIDNEY DISEASE 3964 0.0521
29 ACINETOBACTER INFECTION 56 0.0511
30 CLOSTRIDIUM TEST POSITIVE 109 0.0494
31 LIGAMENT INJURY 56 0.0493
32 TUBULOINTERSTITIAL NEPHRITIS 906 0.0483
33 FISTULA DISCHARGE 60 0.0475
34 PATHOGEN RESISTANCE 433 0.0475
35 PROCTITIS 131 0.0467
36 PLANTAR FASCIITIS 156 0.0465
37 WEIGHT BEARING DIFFICULTY 124 0.0460
38 CLOSTRIDIUM DIFFICILE COLITIS 479 0.0451
39 LINEAR IGA DISEASE 73 0.0438
40 FOOD INTOLERANCE 159 0.0434
41 MEGACOLON 67 0.0426
42 LOSS OF EMPLOYMENT 127 0.0420
43 FUNGAEMIA 64 0.0406
44 TOXIC EPIDERMAL NECROLYSIS 616 0.0405
45 HENOCH-SCHONLEIN PURPURA 88 0.0402
46 PROSTATITIS 120 0.0394
47 HYPERACUSIS 145 0.0389
48 CHRONIC SINUSITIS 146 0.0389
49 PSEUDOMONAS INFECTION 324 0.0377
50 PULMONARY PAIN 106 0.0363
51 RENAL TUBULAR NECROSIS 355 0.0362
52 LUNG CONSOLIDATION 99 0.0354
53 OESOPHAGEAL SPASM 65 0.0352
54 TENOSYNOVITIS 96 0.0348
55 ANAL FISSURE 184 0.0343
56 FIXED ERUPTION 58 0.0337
57 TORSADE DE POINTES 264 0.0336
58 ENTEROCOCCAL INFECTION 162 0.0335
59 ANAL FISTULA 177 0.0331
60 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 180 0.0330
61 SPUTUM INCREASED 70 0.0323
62 MUSCLE CONTRACTIONS INVOLUNTARY 113 0.0321
63 KLEBSIELLA INFECTION 157 0.0310
64 CUTANEOUS VASCULITIS 111 0.0304
65 ANAL ABSCESS 163 0.0302
66 CHOLECYSTITIS CHRONIC 196 0.0292
67 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 753 0.0292
68 MULTIPLE-DRUG RESISTANCE 89 0.0287
69 QUADRIPLEGIA 59 0.0286
70 MUSCLE ATROPHY 363 0.0286
71 ASPERGILLUS INFECTION 187 0.0285
72 FEAR OF DEATH 63 0.0280
73 FISTULA 311 0.0276
74 ACUTE KIDNEY INJURY 4229 0.0276
75 RENAL INJURY 818 0.0275
76 SYSTEMIC CANDIDA 69 0.0275
77 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 209 0.0269
78 DYSAESTHESIA 81 0.0264
79 RASH MORBILLIFORM 73 0.0263
80 NEURALGIA 635 0.0261
81 CLOSTRIDIUM DIFFICILE INFECTION 565 0.0259
82 TOXIC ENCEPHALOPATHY 130 0.0256
83 ESCHERICHIA URINARY TRACT INFECTION 109 0.0256
84 CHOLESTATIC LIVER INJURY 57 0.0256
85 CARTILAGE INJURY 63 0.0255
86 NEUTROPENIC SEPSIS 182 0.0255
87 AUTONOMIC NERVOUS SYSTEM IMBALANCE 74 0.0253
88 MUSCLE TWITCHING 573 0.0248
89 DRUG RESISTANCE 636 0.0247
90 JAUNDICE CHOLESTATIC 86 0.0243
91 ACUTE GRAFT VERSUS HOST DISEASE 109 0.0238
92 NERVE INJURY 264 0.0237
93 BLADDER PAIN 75 0.0236
94 OLIGURIA 143 0.0230
95 BONE EROSION 81 0.0229
96 PYELONEPHRITIS 197 0.0227
97 WOUND COMPLICATION 78 0.0227
98 BRONCHIECTASIS 151 0.0224
99 BLOOD PRESSURE DIASTOLIC ABNORMAL 57 0.0224
100 ECONOMIC PROBLEM 334 0.0220
101 TINNITUS 1008 0.0219
102 ROTATOR CUFF SYNDROME 278 0.0216
103 PNEUMONIA FUNGAL 85 0.0215
104 CREPITATIONS 63 0.0211
105 RENAL FAILURE 2805 0.0211
106 LYMPHOEDEMA 146 0.0211
107 ESCHERICHIA INFECTION 173 0.0210
108 RHINITIS ALLERGIC 93 0.0209
109 STEVENS-JOHNSON SYNDROME 463 0.0208
110 BACTERAEMIA 247 0.0208
111 STAPHYLOCOCCAL SEPSIS 102 0.0206
112 ANXIETY DISORDER 69 0.0206
113 HALLUCINATIONS, MIXED 86 0.0204
114 ABDOMINAL ABSCESS 90 0.0203
115 CYSTIC FIBROSIS 112 0.0202
116 EXERCISE TOLERANCE DECREASED 115 0.0200
117 DRUG LEVEL BELOW THERAPEUTIC 110 0.0199
118 RASH MACULO-PAPULAR 433 0.0194
119 EOSINOPHILIA 338 0.0193
120 BK VIRUS INFECTION 65 0.0193
121 NEPHROPATHY 179 0.0192
122 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 73 0.0191
123 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 62 0.0191
124 POTENTIATING DRUG INTERACTION 64 0.0191
125 CLOSTRIDIAL INFECTION 64 0.0189
126 ABSCESS 301 0.0188
127 UROSEPSIS 174 0.0188
128 HEPATITIS CHOLESTATIC 113 0.0187
129 THROMBOTIC THROMBOCYTOPENIC PURPURA 66 0.0187
130 POLYNEUROPATHY 224 0.0187
131 FAECAL CALPROTECTIN INCREASED 59 0.0186
132 DERMATITIS EXFOLIATIVE GENERALISED 64 0.0184
133 APLASTIC ANAEMIA 96 0.0184
134 FLANK PAIN 172 0.0183
135 VITREOUS FLOATERS 180 0.0183
136 SUBCUTANEOUS ABSCESS 87 0.0181
137 LIGAMENT RUPTURE 80 0.0181
138 NEUROLOGICAL SYMPTOM 103 0.0180
139 TESTICULAR PAIN 57 0.0180
140 IMPAIRED WORK ABILITY 384 0.0179
141 BRONCHOPULMONARY ASPERGILLOSIS 139 0.0179
142 ATELECTASIS 173 0.0179
143 FEBRILE NEUTROPENIA 1187 0.0179
144 FEBRILE BONE MARROW APLASIA 76 0.0179
145 FOOD ALLERGY 138 0.0179
146 DRUG INTERACTION 2833 0.0178
147 ANHEDONIA 468 0.0178
148 DERMATITIS EXFOLIATIVE 89 0.0178
149 RESPIRATORY TRACT INFECTION 462 0.0177
150 PHOTOSENSITIVITY REACTION 292 0.0177
151 PROCTALGIA 113 0.0176
152 NEUROPATHY PERIPHERAL 1662 0.0175
153 ORAL CANDIDIASIS 230 0.0174
154 PANIC ATTACK 632 0.0173
155 PURULENT DISCHARGE 74 0.0173
156 SKIN INJURY 57 0.0172
157 CANDIDA INFECTION 288 0.0170
158 ENDOCARDITIS 87 0.0169
159 PERIPHERAL SENSORY NEUROPATHY 99 0.0169
160 SEPTIC SHOCK 736 0.0169
161 NECROSIS 94 0.0169
162 LEUKOCYTOSIS 305 0.0168
163 OEDEMA 911 0.0168
164 INFLAMMATORY MARKER INCREASED 83 0.0167
165 NECROTISING FASCIITIS 59 0.0167
166 OESOPHAGEAL PAIN 66 0.0167
167 MYOCLONUS 199 0.0167
168 ENDOPHTHALMITIS 99 0.0165
169 CANDIDIASIS 66 0.0164
170 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 83 0.0164
171 GRAFT VERSUS HOST DISEASE 117 0.0163
172 MUCOSAL INFLAMMATION 423 0.0161
173 TENDERNESS 168 0.0161
174 HEPATIC ENCEPHALOPATHY 150 0.0161
175 COLITIS 609 0.0160
176 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 142 0.0160
177 CHOLECYSTITIS ACUTE 91 0.0160
178 GROIN PAIN 141 0.0160
179 DERMATITIS BULLOUS 116 0.0160
180 MULTI-ORGAN FAILURE 276 0.0159
181 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 163 0.0159
182 STAPHYLOCOCCAL BACTERAEMIA 69 0.0159
183 ABDOMINAL TENDERNESS 78 0.0157
184 METABOLIC DISORDER 91 0.0157
185 VASCULAR DEVICE INFECTION 71 0.0156
186 ENTERITIS 100 0.0156
187 NEPHROPATHY TOXIC 175 0.0156
188 MULTIPLE ORGAN DYSFUNCTION SYNDROME 439 0.0155
189 ANURIA 133 0.0154
190 HEPATIC CYTOLYSIS 197 0.0154
191 DIVERTICULITIS 426 0.0154
192 HYDRONEPHROSIS 115 0.0153
193 MUSCLE FATIGUE 65 0.0153
194 HYPOMANIA 56 0.0152
195 CYSTITIS 482 0.0151
196 DIVERTICULUM INTESTINAL 66 0.0151
197 DIVERTICULUM 107 0.0150
198 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 75 0.0150
199 PARAESTHESIA ORAL 217 0.0150
200 NASAL POLYPS 74 0.0150
201 DEVICE RELATED INFECTION 231 0.0150
202 GUILLAIN-BARRE SYNDROME 72 0.0149
203 WHEEZING 876 0.0148
204 ODYNOPHAGIA 88 0.0147
205 LUNG INFILTRATION 130 0.0147
206 PHLEBITIS 75 0.0146
207 APHTHOUS ULCER 113 0.0146
208 MYOPATHY 125 0.0145
209 GASTROINTESTINAL PAIN 159 0.0144
210 CYSTITIS HAEMORRHAGIC 58 0.0144
211 HYPERBILIRUBINAEMIA 148 0.0143
212 RENAL FAILURE ACUTE 602 0.0142
213 QUALITY OF LIFE DECREASED 190 0.0141
214 ELECTROCARDIOGRAM QT PROLONGED 504 0.0140
215 BLOOD CREATINE INCREASED 62 0.0140
216 VENOOCCLUSIVE LIVER DISEASE 69 0.0140
217 HAEMOLYTIC ANAEMIA 125 0.0139
218 MYALGIA 2349 0.0138
219 MYOSITIS 123 0.0137
220 SARCOIDOSIS 65 0.0137
221 PURPURA 121 0.0137
222 SPINAL OSTEOARTHRITIS 120 0.0136
223 HEPATIC STEATOSIS 254 0.0136
224 ABSCESS LIMB 58 0.0136
225 CATATONIA 71 0.0135
226 FORMICATION 94 0.0135
227 PHOTOPHOBIA 253 0.0134
228 URINE ABNORMALITY 61 0.0134
229 DRUG LEVEL INCREASED 222 0.0134
230 BLOOD PRESSURE DIASTOLIC DECREASED 98 0.0133
231 MUSCLE TIGHTNESS 215 0.0133
232 HAEMODYNAMIC INSTABILITY 101 0.0132
233 CHOLESTASIS 254 0.0132
234 RENAL CYST 105 0.0132
235 VASCULITIS 154 0.0132
236 BURNING SENSATION 926 0.0132
237 DRUG LEVEL ABOVE THERAPEUTIC 60 0.0131
238 PROTHROMBIN TIME PROLONGED 78 0.0130
239 PARAESTHESIA 2051 0.0130
240 PATHOLOGICAL FRACTURE 66 0.0130
241 DISSEMINATED INTRAVASCULAR COAGULATION 183 0.0130
242 BENIGN PROSTATIC HYPERPLASIA 67 0.0130
243 MUSCULAR WEAKNESS 1472 0.0129
244 ARTHRITIS INFECTIVE 60 0.0129
245 INTESTINAL ISCHAEMIA 71 0.0129
246 PANCYTOPENIA 718 0.0128
247 UMBILICAL HERNIA 60 0.0128
248 SYNOVIAL CYST 59 0.0128
249 TOXIC SKIN ERUPTION 128 0.0127
250 SENSORY DISTURBANCE 202 0.0126
251 TACHYPNOEA 171 0.0126
252 MEDICATION ERROR 697 0.0125
253 BURSITIS 152 0.0125
254 C-REACTIVE PROTEIN ABNORMAL 80 0.0125
255 STAPHYLOCOCCAL INFECTION 411 0.0124
256 GINGIVITIS 67 0.0124
257 ACUTE HEPATIC FAILURE 169 0.0124
258 FIBROMYALGIA 300 0.0123
259 PERFORMANCE STATUS DECREASED 57 0.0122
260 ACUTE RESPIRATORY DISTRESS SYNDROME 216 0.0122
261 TRICUSPID VALVE INCOMPETENCE 97 0.0122
262 NERVOUS SYSTEM DISORDER 381 0.0122
263 MOUTH ULCERATION 257 0.0122
264 ABNORMAL LOSS OF WEIGHT 83 0.0122
265 BREATH SOUNDS ABNORMAL 60 0.0122
266 GASTROOESOPHAGEAL REFLUX DISEASE 979 0.0121
267 AGRANULOCYTOSIS 225 0.0121
268 MALNUTRITION 135 0.0121
269 C-REACTIVE PROTEIN INCREASED 438 0.0120
270 EXTRASYSTOLES 84 0.0120
271 CARDIAC MURMUR 104 0.0120
272 DRUG LEVEL DECREASED 122 0.0120
273 WALKING AID USER 79 0.0120
274 PETECHIAE 125 0.0120
275 NEUROTOXICITY 209 0.0119
276 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 113 0.0118
277 HAEMATURIA 404 0.0118
278 MUSCULOSKELETAL PAIN 618 0.0118
279 HYPOVOLAEMIA 69 0.0118
280 MITRAL VALVE INCOMPETENCE 133 0.0117
281 DYSURIA 432 0.0117
282 MENISCUS INJURY 72 0.0117
283 DRUG-INDUCED LIVER INJURY 367 0.0117
284 EAR PAIN 227 0.0117
285 ANORECTAL DISCOMFORT 62 0.0117
286 MUSCLE DISORDER 94 0.0116
287 RHABDOMYOLYSIS 482 0.0115
288 TEMPERATURE INTOLERANCE 119 0.0115
289 BACTERIAL INFECTION 215 0.0115
290 INTERNATIONAL NORMALISED RATIO INCREASED 328 0.0115
291 CHOLECYSTITIS 137 0.0115
292 CEREBRAL ISCHAEMIA 59 0.0115
293 VAGINAL DISCHARGE 116 0.0115
294 CYTOMEGALOVIRUS INFECTION 190 0.0114
295 JAUNDICE 307 0.0114
296 GASTROINTESTINAL INFLAMMATION 89 0.0114
297 PERIPHERAL COLDNESS 156 0.0113
298 OSTEOMYELITIS 205 0.0113
299 SEPSIS 1261 0.0113
300 CACHEXIA 58 0.0113
301 RALES 65 0.0112
302 SKIN NECROSIS 58 0.0112
303 JOINT STIFFNESS 292 0.0111
304 COAGULOPATHY 185 0.0111
305 POST-TRAUMATIC STRESS DISORDER 74 0.0110
306 CYTOKINE RELEASE SYNDROME 221 0.0110
307 FREQUENT BOWEL MOVEMENTS 297 0.0110
308 VENTRICULAR EXTRASYSTOLES 114 0.0110
309 HEPATOTOXICITY 244 0.0109
310 BLOOD BILIRUBIN INCREASED 296 0.0109
311 HYPOMAGNESAEMIA 152 0.0109
312 OSTEOPENIA 165 0.0109
313 URINARY TRACT INFECTION 1847 0.0108
314 CIRCULATORY COLLAPSE 184 0.0108
315 MULTIPLE INJURIES 68 0.0108
316 SPINAL PAIN 126 0.0107
317 ATAXIA 127 0.0107
318 COLITIS ISCHAEMIC 72 0.0107
319 OBESITY 170 0.0107
320 RENAL PAIN 113 0.0106
321 ANXIETY 3026 0.0106
322 RENAL IMPAIRMENT 893 0.0106
323 KIDNEY INFECTION 208 0.0106
324 GASTROINTESTINAL INFECTION 95 0.0106
325 JOINT DISLOCATION 112 0.0106
326 PERONEAL NERVE PALSY 60 0.0105
327 HYPOAESTHESIA 1573 0.0105
328 ABDOMINAL PAIN LOWER 265 0.0105
329 DRUG ERUPTION 185 0.0104
330 NIGHT SWEATS 336 0.0104
331 SWOLLEN TONGUE 325 0.0104
332 ENTEROCOLITIS 60 0.0104
333 DELIRIUM 360 0.0104
334 SINUS TACHYCARDIA 147 0.0103
335 MACULAR DEGENERATION 123 0.0103
336 IMPAIRED QUALITY OF LIFE 148 0.0103
337 MUSCLE STRAIN 89 0.0103
338 THROMBOCYTOPENIA 1147 0.0102
339 BLOOD PRESSURE SYSTOLIC INCREASED 200 0.0102
340 DISTURBANCE IN ATTENTION 552 0.0102
341 CHOLELITHIASIS 335 0.0102
342 PAROSMIA 77 0.0102
343 HAEMATOCRIT DECREASED 202 0.0102
344 DECUBITUS ULCER 83 0.0102
345 HEPATOMEGALY 100 0.0102
346 MUSCULOSKELETAL DISCOMFORT 175 0.0102
347 SMALL INTESTINAL OBSTRUCTION 125 0.0101
348 SKIN WARM 59 0.0101
349 INFLAMMATION 522 0.0101
350 PANIC REACTION 73 0.0101
351 ABORTION SPONTANEOUS 404 0.0101
352 BRAIN FOG 158 0.0101
353 MUSCULOSKELETAL CHEST PAIN 156 0.0101
354 NECK PAIN 563 0.0101
355 URINE ODOUR ABNORMAL 59 0.0100
356 SPUTUM DISCOLOURED 95 0.0100
357 ABNORMAL FAECES 82 0.0100
358 HAEMODIALYSIS 84 0.0100
359 ELECTROLYTE IMBALANCE 116 0.0100
360 GENERALISED TONIC-CLONIC SEIZURE 165 0.0100
361 ARTERIOSCLEROSIS CORONARY ARTERY 66 0.0100
362 HYPOKALAEMIA 459 0.0099
363 PHARYNGEAL SWELLING 97 0.0099
364 ERYTHEMA MULTIFORME 92 0.0099
365 BODY TEMPERATURE DECREASED 97 0.0098
366 HAEMOLYSIS 76 0.0098
367 ARTHRALGIA 4088 0.0098
368 VULVOVAGINAL BURNING SENSATION 60 0.0098
369 SENSORY LOSS 79 0.0098
370 POLYURIA 80 0.0098
371 HEPATIC FAILURE 294 0.0097
372 HYPERAESTHESIA 80 0.0097
373 DIARRHOEA HAEMORRHAGIC 91 0.0097
374 INTERVERTEBRAL DISC DEGENERATION 90 0.0097
375 POST PROCEDURAL INFECTION 79 0.0097
376 MULTIPLE ALLERGIES 76 0.0097
377 CARDIOMEGALY 118 0.0096
378 MENINGITIS 64 0.0096
379 PALPITATIONS 1117 0.0095
380 LEUKOPENIA 476 0.0095
381 CROHN'S DISEASE 65 0.0095
382 ABDOMINAL PAIN 2203 0.0095
383 AORTIC ANEURYSM 72 0.0095
384 LOWER RESPIRATORY TRACT INFECTION 430 0.0094
385 THERMAL BURN 67 0.0094
386 ARRHYTHMIA 447 0.0094
387 HYPOGAMMAGLOBULINAEMIA 62 0.0094
388 ENCEPHALOPATHY 231 0.0094
389 PYREXIA 3236 0.0093
390 OESOPHAGITIS 102 0.0093
391 ECCHYMOSIS 64 0.0093
392 VENTRICULAR TACHYCARDIA 154 0.0093
393 BLOOD CREATININE INCREASED 608 0.0093
394 GALLBLADDER DISORDER 166 0.0093
395 PAIN IN EXTREMITY 2739 0.0093
396 GENERALISED OEDEMA 115 0.0093
397 EYELID OEDEMA 108 0.0093
398 IRRITABLE BOWEL SYNDROME 199 0.0093
399 URINE OUTPUT DECREASED 81 0.0093
400 INTESTINAL PERFORATION 104 0.0093
401 OBSTRUCTIVE AIRWAYS DISORDER 103 0.0093
402 HEPATOCELLULAR INJURY 131 0.0092
403 HEPATITIS ACUTE 60 0.0092
404 METABOLIC ACIDOSIS 295 0.0092
405 PARANOIA 159 0.0092
406 APPETITE DISORDER 61 0.0092
407 CHOLANGITIS 57 0.0092
408 BLOOD ALKALINE PHOSPHATASE INCREASED 228 0.0092
409 HYPONATRAEMIA 517 0.0092
410 DEFAECATION URGENCY 64 0.0091
411 BODY TEMPERATURE INCREASED 186 0.0091
412 URINARY RETENTION 304 0.0091
413 TUMOUR LYSIS SYNDROME 80 0.0091
414 EAR DISCOMFORT 93 0.0091
415 RESPIRATORY FAILURE 659 0.0090
416 ARTERIOSCLEROSIS 85 0.0090
417 TACHYCARDIA 802 0.0090
418 SLEEP APNOEA SYNDROME 172 0.0090
419 HAEMATOCHEZIA 495 0.0090
420 FACE OEDEMA 151 0.0089
421 RED BLOOD CELL SEDIMENTATION RATE INCREASED 99 0.0089
422 HEART RATE IRREGULAR 202 0.0089
423 HYPOTONIA 88 0.0088
424 DEPRESSION 1993 0.0088
425 RESTLESSNESS 320 0.0087
426 HIATUS HERNIA 113 0.0087
427 ACUTE MYELOID LEUKAEMIA 136 0.0087
428 MENTAL STATUS CHANGES 241 0.0087
429 WOUND INFECTION 95 0.0087
430 LEFT VENTRICULAR DYSFUNCTION 58 0.0087
431 NEUTROPENIA 1173 0.0086
432 UVEITIS 117 0.0086
433 SPLENOMEGALY 101 0.0086
434 HAEMATOMA 223 0.0086
435 PSYCHOTIC DISORDER 254 0.0086
436 POSTOPERATIVE WOUND INFECTION 58 0.0086
437 PSYCHOLOGICAL TRAUMA 74 0.0086
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 190 0.0086
439 PULMONARY CONGESTION 113 0.0086
440 ANAL INCONTINENCE 77 0.0086
441 FUNGAL INFECTION 285 0.0085
442 APHASIA 258 0.0085
443 MOTOR DYSFUNCTION 87 0.0085
444 ACUTE RESPIRATORY FAILURE 164 0.0085
445 HALLUCINATION 642 0.0085
446 GASTROENTERITIS 124 0.0085
447 INJURY 597 0.0085
448 HYPOALBUMINAEMIA 66 0.0085
449 RESPIRATORY DISTRESS 234 0.0085
450 BLOOD UREA INCREASED 141 0.0084
451 BLOOD PRESSURE FLUCTUATION 202 0.0084
452 DEAFNESS 220 0.0084
453 JOINT EFFUSION 58 0.0084
454 OSTEOARTHRITIS 356 0.0084
455 CONTRAINDICATED PRODUCT ADMINISTERED 254 0.0084
456 PHARYNGITIS 104 0.0084
457 NEPHROLITHIASIS 384 0.0084
458 HYPERKALAEMIA 293 0.0083
459 HYPOXIA 294 0.0083
460 MUSCULOSKELETAL STIFFNESS 731 0.0083
461 MUSCLE INJURY 69 0.0083
462 EXOSTOSIS 76 0.0083
463 BLOOD ALBUMIN DECREASED 66 0.0083
464 MICTURITION URGENCY 95 0.0083
465 COORDINATION ABNORMAL 116 0.0083
466 GAIT DISTURBANCE 1587 0.0083
467 VENTRICULAR FIBRILLATION 92 0.0083
468 LIVER FUNCTION TEST ABNORMAL 240 0.0082
469 SLEEP DISORDER 582 0.0082
470 HEART RATE DECREASED 289 0.0082
471 DENTAL CARIES 91 0.0082
472 RECTAL HAEMORRHAGE 353 0.0082
473 LARGE INTESTINE PERFORATION 57 0.0082
474 EOSINOPHIL COUNT INCREASED 68 0.0082
475 NIGHTMARE 282 0.0081
476 UPPER-AIRWAY COUGH SYNDROME 67 0.0081
477 SWELLING FACE 528 0.0081
478 RASH PUSTULAR 59 0.0081
479 ASCITES 238 0.0081
480 PNEUMONIA 2616 0.0081
481 ANAPHYLACTIC REACTION 445 0.0080
482 AUTOIMMUNE HEPATITIS 56 0.0080
483 TRANSAMINASES INCREASED 179 0.0080
484 SINUS CONGESTION 108 0.0080
485 PULMONARY MASS 119 0.0080
486 RHINITIS 64 0.0079
487 GAIT INABILITY 265 0.0079
488 ORTHOSTATIC HYPOTENSION 138 0.0079
489 SCHIZOPHRENIA 96 0.0079
490 ARTHROPATHY 439 0.0079
491 FAECES DISCOLOURED 171 0.0079
492 ANAEMIA 1502 0.0079
493 HYPERLIPIDAEMIA 94 0.0079
494 ASTHMA 889 0.0079
495 SINUS BRADYCARDIA 76 0.0079
496 CONFUSIONAL STATE 1270 0.0079
497 CELLULITIS 396 0.0079
498 CARPAL TUNNEL SYNDROME 110 0.0078
499 LYMPHADENOPATHY 278 0.0078
500 ALANINE AMINOTRANSFERASE INCREASED 482 0.0078
501 PARALYSIS 112 0.0078
502 DYSPNOEA EXERTIONAL 294 0.0078
503 BLOOD URINE PRESENT 148 0.0078
504 PLEURAL EFFUSION 473 0.0078
505 CHROMATURIA 175 0.0077
506 TRANSPLANT REJECTION 62 0.0077
507 PRODUCTIVE COUGH 369 0.0077
508 FACIAL PAIN 69 0.0077
509 MENTAL IMPAIRMENT 186 0.0077
510 ABASIA 189 0.0076
511 ATRIAL FLUTTER 61 0.0076
512 ILEUS 95 0.0076
513 HAEMORRHOIDS 149 0.0076
514 PROTEINURIA 145 0.0076
515 HALLUCINATION, VISUAL 161 0.0076
516 HEPATITIS 195 0.0076
517 SKIN LESION 209 0.0076
518 SHOCK HAEMORRHAGIC 62 0.0076
519 SPINAL DISORDER 72 0.0076
520 PAIN IN JAW 215 0.0076
521 BONE MARROW FAILURE 154 0.0076
522 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 364 0.0076
523 MUSCULOSKELETAL DISORDER 144 0.0076
524 GENERAL PHYSICAL HEALTH DETERIORATION 874 0.0075
525 PULMONARY HAEMORRHAGE 59 0.0075
526 BEDRIDDEN 99 0.0075
527 LIMB DISCOMFORT 233 0.0075
528 URINARY INCONTINENCE 222 0.0075
529 DYSPEPSIA 737 0.0075
530 ADVERSE REACTION 99 0.0075
531 SKIN ULCER 193 0.0075
532 DYSSTASIA 218 0.0075
533 EYE PAIN 420 0.0074
534 BONE DISORDER 135 0.0074
535 THROMBOTIC MICROANGIOPATHY 72 0.0074
536 DEFORMITY 69 0.0074
537 ACUTE CORONARY SYNDROME 61 0.0074
538 SUBARACHNOID HAEMORRHAGE 75 0.0074
539 CHEST PAIN 1362 0.0073
540 ANGIOEDEMA 325 0.0073
541 BALANCE DISORDER 635 0.0073
542 DISORIENTATION 291 0.0073
543 GASTRITIS 193 0.0073
544 RESPIRATORY RATE INCREASED 65 0.0073
545 SHOCK 168 0.0073
546 ACTIVITIES OF DAILY LIVING IMPAIRED 144 0.0073
547 WHITE BLOOD CELL COUNT INCREASED 279 0.0073
548 CONDITION AGGRAVATED 2205 0.0072
549 UPPER GASTROINTESTINAL HAEMORRHAGE 122 0.0072
550 NOCTURIA 88 0.0072
551 ASPARTATE AMINOTRANSFERASE INCREASED 383 0.0072
552 JOINT SWELLING 870 0.0072
553 BLOOD LACTATE DEHYDROGENASE INCREASED 114 0.0072
554 HEAD DISCOMFORT 127 0.0072
555 DECREASED ACTIVITY 77 0.0071
556 BLOOD DISORDER 57 0.0071
557 SKIN PLAQUE 60 0.0071
558 PELVIC PAIN 129 0.0071
559 PERITONITIS 147 0.0071
560 DEHYDRATION 945 0.0071
561 LIGAMENT SPRAIN 70 0.0071
562 OEDEMA PERIPHERAL 862 0.0071
563 NEUTROPHIL COUNT DECREASED 288 0.0071
564 PNEUMOTHORAX 112 0.0071
565 BACK PAIN 1632 0.0070
566 DYSPHONIA 410 0.0070
567 OVARIAN CYST 70 0.0070
568 MANIA 115 0.0070
569 EMBOLISM 58 0.0070
570 PNEUMONIA ASPIRATION 174 0.0070
571 MUSCLE SPASMS 1274 0.0069
572 PAIN 4260 0.0069
573 ORAL PAIN 155 0.0069
574 HAEMOPTYSIS 193 0.0069
575 INTRAOCULAR PRESSURE INCREASED 88 0.0069
576 EJECTION FRACTION DECREASED 107 0.0069
577 TREMOR 1142 0.0069
578 INSOMNIA 1831 0.0069
579 PNEUMOCYSTIS JIROVECII PNEUMONIA 69 0.0069
580 VITAMIN D DEFICIENCY 67 0.0069
581 LYMPHOPENIA 97 0.0069
582 PANCREATITIS ACUTE 154 0.0068
583 THROAT TIGHTNESS 185 0.0068
584 NEUTROPHIL COUNT INCREASED 70 0.0068
585 THINKING ABNORMAL 127 0.0068
586 GASTROINTESTINAL DISORDER 610 0.0068
587 FACIAL PARALYSIS 58 0.0068
588 ATRIAL FIBRILLATION 661 0.0068
589 LIP SWELLING 226 0.0068
590 COLITIS ULCERATIVE 303 0.0068
591 DIPLOPIA 176 0.0068
592 POOR VENOUS ACCESS 70 0.0068
593 PNEUMONITIS 184 0.0068
594 NAIL DISORDER 59 0.0067
595 VOMITING 3170 0.0067
596 STATUS EPILEPTICUS 76 0.0067
597 DRUG INTOLERANCE 650 0.0067
598 INTERVERTEBRAL DISC PROTRUSION 147 0.0067
599 INCONTINENCE 71 0.0067
600 SUICIDAL IDEATION 613 0.0067
601 DRUG TOXICITY 91 0.0067
602 DYSPHAGIA 633 0.0067
603 OSTEOPOROSIS 274 0.0067
604 LOCALISED INFECTION 161 0.0067
605 MOBILITY DECREASED 478 0.0066
606 RASH ERYTHEMATOUS 318 0.0066
607 BLOOD POTASSIUM DECREASED 200 0.0066
608 DEEP VEIN THROMBOSIS 431 0.0066
609 CYANOSIS 104 0.0066
610 SEROTONIN SYNDROME 127 0.0066
611 BLOOD MAGNESIUM DECREASED 57 0.0066
612 ULCER 105 0.0066
613 SKIN INFECTION 74 0.0066
614 ASTHENIA 2477 0.0066
615 MASS 92 0.0066
616 TOOTHACHE 119 0.0066
617 SWELLING 614 0.0066
618 INFECTION 948 0.0065
619 CYTOPENIA 80 0.0065
620 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 357 0.0065
621 BLISTER 365 0.0065
622 SECRETION DISCHARGE 81 0.0065
623 MENTAL DISORDER 281 0.0065
624 DIARRHOEA 4165 0.0064
625 EMPHYSEMA 65 0.0064
626 SCAR 110 0.0064
627 JOINT RANGE OF MOTION DECREASED 86 0.0064
628 CHILLS 751 0.0064
629 AGITATION 470 0.0064
630 IMPAIRED HEALING 210 0.0064
631 LIVER INJURY 157 0.0064
632 FEAR 172 0.0064
633 TOOTH INFECTION 84 0.0064
634 ABDOMINAL PAIN UPPER 1309 0.0064
635 WEIGHT DECREASED 1770 0.0063
636 HAEMOGLOBIN DECREASED 650 0.0063
637 HEART RATE INCREASED 626 0.0063
638 VISUAL IMPAIRMENT 783 0.0063
639 LUNG INFECTION 98 0.0063
640 ORAL HERPES 123 0.0063
641 ASPIRATION 69 0.0063
642 IMMUNE SYSTEM DISORDER 83 0.0063
643 WOUND 176 0.0063
644 VISUAL ACUITY REDUCED 208 0.0063
645 EPILEPSY 191 0.0062
646 POLLAKIURIA 260 0.0062
647 DYSARTHRIA 234 0.0062
648 EYE INFECTION 70 0.0062
649 HEMIPARESIS 105 0.0062
650 IRON DEFICIENCY ANAEMIA 57 0.0062
651 BRONCHOSPASM 88 0.0062
652 IMPAIRED GASTRIC EMPTYING 84 0.0062
653 RASH PAPULAR 138 0.0062
654 SYNCOPE 615 0.0061
655 PULMONARY EMBOLISM 583 0.0061
656 INTERSTITIAL LUNG DISEASE 297 0.0061
657 DERMATITIS ALLERGIC 77 0.0061
658 COUGH 1716 0.0061
659 TASTE DISORDER 124 0.0061
660 HYPOPHAGIA 156 0.0061
661 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
662 GRAND MAL CONVULSION 56 0.0061
663 CARDIOGENIC SHOCK 87 0.0061
664 EMOTIONAL DISTRESS 734 0.0061
665 HYPOTENSION 1214 0.0060
666 ARTHRITIS 476 0.0060
667 HALLUCINATION, AUDITORY 96 0.0060
668 JOINT INJURY 129 0.0060
669 HAEMATEMESIS 153 0.0060
670 ADRENAL INSUFFICIENCY 73 0.0060
671 DYSPNOEA 3400 0.0060
672 FEELING COLD 167 0.0060
673 RESTLESS LEGS SYNDROME 109 0.0060
674 VERTIGO 365 0.0060
675 IMPAIRED DRIVING ABILITY 68 0.0060
676 HYPOCALCAEMIA 113 0.0060
677 DECREASED APPETITE 1386 0.0060
678 DISABILITY 118 0.0060
679 HYPERSENSITIVITY 1103 0.0059
680 BONE PAIN 348 0.0059
681 THERAPEUTIC PRODUCT EFFECT DECREASED 265 0.0059
682 HYPERHIDROSIS 762 0.0059
683 DEPRESSED MOOD 312 0.0059
684 HEPATIC ENZYME INCREASED 402 0.0059
685 RENAL DISORDER 274 0.0059
686 MYELODYSPLASTIC SYNDROME 85 0.0059
687 PROCEDURAL PAIN 163 0.0059
688 MALAISE 2566 0.0058
689 PERICARDIAL EFFUSION 135 0.0058
690 BLOOD SODIUM DECREASED 110 0.0058
691 SCAB 66 0.0058
692 ABDOMINAL DISTENSION 604 0.0058
693 LACTIC ACIDOSIS 187 0.0058
694 RASH PRURITIC 312 0.0058
695 COGNITIVE DISORDER 268 0.0057
696 URTICARIA 961 0.0057
697 PRESYNCOPE 139 0.0057
698 THIRST 102 0.0057
699 LIVER DISORDER 253 0.0057
700 HAEMORRHAGE INTRACRANIAL 85 0.0057
701 GOUT 102 0.0057
702 RASH 2477 0.0057
703 RASH GENERALISED 147 0.0057
704 UPPER RESPIRATORY TRACT INFECTION 262 0.0057
705 NODULE 74 0.0057
706 CONJUNCTIVITIS 105 0.0057
707 DYSKINESIA 230 0.0057
708 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 295 0.0056
709 INITIAL INSOMNIA 58 0.0056
710 FOLLICULITIS 59 0.0056
711 CONSTIPATION 1227 0.0056
712 HYPERGLYCAEMIA 205 0.0056
713 CARDIOMYOPATHY 83 0.0056
714 FATIGUE 4367 0.0056
715 ABDOMINAL DISCOMFORT 940 0.0056
716 LETHARGY 322 0.0056
717 BRAIN INJURY 56 0.0056
718 VISION BLURRED 766 0.0056
719 DRY EYE 278 0.0056
720 ERYTHEMA 1142 0.0055
721 HYPOGLYCAEMIA 268 0.0055
722 CARDIAC ARREST 454 0.0055
723 BRADYCARDIA 291 0.0055
724 EAR INFECTION 146 0.0055
725 HEPATIC CIRRHOSIS 103 0.0055
726 CARDIOVASCULAR DISORDER 139 0.0055
727 AMNESIA 356 0.0055
728 TOXICITY TO VARIOUS AGENTS 921 0.0055
729 PRURITUS GENERALISED 118 0.0055
730 OSTEONECROSIS OF JAW 135 0.0054
731 COLD SWEAT 96 0.0054
732 MUSCLE RIGIDITY 65 0.0054
733 POOR QUALITY SLEEP 117 0.0054
734 BONE DENSITY DECREASED 170 0.0054
735 PRODUCT PRESCRIBING ISSUE 118 0.0054
736 OROPHARYNGEAL PAIN 501 0.0054
737 MELAENA 119 0.0054
738 BRAIN OEDEMA 68 0.0054
739 PULMONARY FIBROSIS 103 0.0054
740 INTENTIONAL PRODUCT USE ISSUE 470 0.0054
741 GASTRIC DISORDER 184 0.0054
742 HYPERCALCAEMIA 66 0.0053
743 CHOLECYSTECTOMY 61 0.0053
744 SYNOVITIS 96 0.0053
745 HYPERTENSION 1126 0.0053
746 INTESTINAL OBSTRUCTION 200 0.0053
747 MIDDLE INSOMNIA 99 0.0053
748 PULMONARY OEDEMA 237 0.0053
749 FLUID OVERLOAD 77 0.0053
750 PERIPHERAL SWELLING 813 0.0053
751 NAUSEA 4169 0.0053
752 PHARYNGEAL OEDEMA 81 0.0053
753 BLOOD CALCIUM DECREASED 59 0.0052
754 CARDIAC FAILURE CONGESTIVE 421 0.0052
755 FOOT DEFORMITY 58 0.0052
756 RESPIRATORY DEPRESSION 64 0.0052
757 PLATELET COUNT DECREASED 556 0.0052
758 RIB FRACTURE 107 0.0052
759 BRONCHITIS 385 0.0052
760 PALLOR 141 0.0052
761 STOMATITIS 312 0.0051
762 LUNG DISORDER 251 0.0051
763 METASTASES TO BONE 84 0.0051
764 MOVEMENT DISORDER 164 0.0051
765 DERMATITIS CONTACT 58 0.0051
766 DIZZINESS 2536 0.0051
767 CONTUSION 489 0.0051
768 RASH MACULAR 177 0.0051
769 CARDIAC FAILURE 406 0.0051
770 PRODUCT PRESCRIBING ERROR 120 0.0050
771 DELUSION 78 0.0050
772 HYPOTHYROIDISM 160 0.0050
773 CHEST DISCOMFORT 513 0.0050
774 OXYGEN SATURATION DECREASED 281 0.0050
775 MIGRAINE 477 0.0050
776 MYOCARDITIS 57 0.0050
777 BLOOD IRON DECREASED 59 0.0050
778 BLOOD PRESSURE DECREASED 328 0.0049
779 APATHY 72 0.0049
780 NO THERAPEUTIC RESPONSE 60 0.0049
781 CYST 61 0.0049
782 PLATELET COUNT INCREASED 64 0.0049
783 DEPRESSED LEVEL OF CONSCIOUSNESS 194 0.0049
784 HAND DEFORMITY 64 0.0049
785 DIALYSIS 69 0.0049
786 INFUSION RELATED REACTION 322 0.0049
787 ORAL DISCOMFORT 67 0.0048
788 UNRESPONSIVE TO STIMULI 124 0.0048
789 RED BLOOD CELL COUNT DECREASED 137 0.0048
790 EYE SWELLING 178 0.0048
791 SKIN DISORDER 159 0.0048
792 ALTERED STATE OF CONSCIOUSNESS 103 0.0047
793 PSYCHOMOTOR HYPERACTIVITY 78 0.0047
794 SEDATION 123 0.0047
795 FOOT FRACTURE 89 0.0047
796 GASTROINTESTINAL HAEMORRHAGE 390 0.0047
797 EPISTAXIS 349 0.0047
798 TREATMENT FAILURE 386 0.0047
799 GASTROENTERITIS VIRAL 84 0.0046
800 FEELING HOT 285 0.0046
801 SCIATICA 74 0.0046
802 EMOTIONAL DISORDER 143 0.0046
803 DRY MOUTH 375 0.0046
804 FLATULENCE 262 0.0046
805 EATING DISORDER 98 0.0046
806 HEADACHE 2885 0.0046
807 SINUSITIS 471 0.0046
808 LYMPHOCYTE COUNT DECREASED 81 0.0046
809 SEIZURE 529 0.0046
810 MEMORY IMPAIRMENT 629 0.0046
811 HYPOACUSIS 196 0.0045
812 SUBDURAL HAEMATOMA 65 0.0045
813 DISEASE PROGRESSION 537 0.0045
814 TOOTH LOSS 94 0.0045
815 BLOOD TRIGLYCERIDES INCREASED 80 0.0045
816 CEREBRAL HAEMORRHAGE 161 0.0045
817 NASAL CONGESTION 264 0.0045
818 LOCAL SWELLING 78 0.0045
819 PULMONARY HYPERTENSION 93 0.0045
820 KNEE ARTHROPLASTY 93 0.0044
821 FEELING ABNORMAL 1056 0.0044
822 GINGIVAL BLEEDING 60 0.0044
823 WHITE BLOOD CELL COUNT DECREASED 476 0.0044
824 DERMATITIS 91 0.0043
825 PRURITUS 1660 0.0043
826 RESPIRATORY DISORDER 129 0.0043
827 ACUTE MYOCARDIAL INFARCTION 127 0.0043
828 CENTRAL NERVOUS SYSTEM LESION 59 0.0043
829 DISEASE RECURRENCE 203 0.0043
830 CONVULSION 244 0.0043
831 BLOOD PRESSURE INCREASED 650 0.0042
832 DYSTONIA 82 0.0042
833 HYPOAESTHESIA ORAL 63 0.0042
834 THERAPY NON-RESPONDER 187 0.0042
835 GASTRIC ULCER 79 0.0042
836 HEPATIC FUNCTION ABNORMAL 155 0.0041
837 EXTRAPYRAMIDAL DISORDER 103 0.0041
838 CORONARY ARTERY DISEASE 125 0.0041
839 ABNORMAL DREAMS 113 0.0041
840 DYSGEUSIA 304 0.0041
841 BLOOD COUNT ABNORMAL 62 0.0041
842 PAIN OF SKIN 110 0.0041
843 PRODUCT USE IN UNAPPROVED INDICATION 1006 0.0041
844 EYE DISORDER 133 0.0040
845 LOSS OF CONSCIOUSNESS 517 0.0040
846 FLUID RETENTION 205 0.0040
847 CARDIO-RESPIRATORY ARREST 168 0.0040
848 LIMB INJURY 109 0.0040
849 OFF LABEL USE 3495 0.0040
850 RESPIRATORY ARREST 110 0.0040
851 BLOOD PRESSURE ABNORMAL 79 0.0040
852 CRYING 144 0.0040
853 IMMUNODEFICIENCY 59 0.0040
854 THYROID DISORDER 61 0.0040
855 ANGINA PECTORIS 113 0.0039
856 ANKLE FRACTURE 61 0.0039
857 GLOSSODYNIA 88 0.0039
858 FEEDING DISORDER 79 0.0039
859 SNEEZING 87 0.0039
860 LIVER FUNCTION TEST INCREASED 83 0.0039
861 SPEECH DISORDER 202 0.0039
862 DIABETES MELLITUS 293 0.0038
863 PANCREATITIS 203 0.0038
864 ALOPECIA 753 0.0038
865 SKIN DISCOLOURATION 176 0.0038
866 DISCOMFORT 233 0.0038
867 ANAPHYLACTIC SHOCK 98 0.0038
868 EXPOSURE DURING PREGNANCY 235 0.0038
869 LABORATORY TEST ABNORMAL 111 0.0038
870 BLOOD POTASSIUM INCREASED 61 0.0038
871 NERVOUSNESS 196 0.0037
872 TARDIVE DYSKINESIA 105 0.0037
873 BASAL CELL CARCINOMA 58 0.0037
874 POST PROCEDURAL COMPLICATION 71 0.0037
875 HERPES ZOSTER 212 0.0037
876 SOMNOLENCE 738 0.0037
877 RESPIRATORY TRACT CONGESTION 58 0.0036
878 METASTASES TO LIVER 64 0.0036
879 HYPERSOMNIA 103 0.0036
880 THROAT IRRITATION 161 0.0036
881 HIP FRACTURE 115 0.0036
882 DIABETES MELLITUS INADEQUATE CONTROL 63 0.0036
883 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 253 0.0036
884 SKIN EXFOLIATION 300 0.0036
885 ERECTILE DYSFUNCTION 91 0.0035
886 MULTIPLE FRACTURES 58 0.0035
887 RHINORRHOEA 228 0.0035
888 CATARACT 210 0.0035
889 RETCHING 75 0.0035
890 AGEUSIA 87 0.0035
891 FALL 1153 0.0035
892 DEMENTIA 96 0.0034
893 THROMBOSIS 270 0.0034
894 HOT FLUSH 252 0.0033
895 HAEMORRHAGE 348 0.0033
896 INFLUENZA 368 0.0033
897 WEIGHT INCREASED 737 0.0033
898 BLOOD CHOLESTEROL INCREASED 153 0.0033
899 SYSTEMIC LUPUS ERYTHEMATOSUS 115 0.0032
900 NASOPHARYNGITIS 595 0.0032
901 GLAUCOMA 62 0.0032
902 MOOD SWINGS 101 0.0032
903 VIRAL INFECTION 105 0.0032
904 ECZEMA 164 0.0031
905 MOOD ALTERED 85 0.0031
906 SKIN BURNING SENSATION 222 0.0031
907 ABNORMAL BEHAVIOUR 121 0.0031
908 DRUG INEFFECTIVE 4011 0.0030
909 SINUS DISORDER 60 0.0030
910 FULL BLOOD COUNT DECREASED 61 0.0030
911 TRANSIENT ISCHAEMIC ATTACK 102 0.0030
912 LACRIMATION INCREASED 91 0.0030
913 TREATMENT NONCOMPLIANCE 164 0.0030
914 PRODUCT USE ISSUE 560 0.0030
915 ILLNESS 306 0.0030
916 UPPER LIMB FRACTURE 59 0.0030
917 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 69 0.0030
918 INFLUENZA LIKE ILLNESS 243 0.0029
919 HERNIA 57 0.0029
920 TOOTH DISORDER 65 0.0029
921 BLINDNESS 119 0.0029
922 ILL-DEFINED DISORDER 176 0.0029
923 PREMATURE BABY 87 0.0029
924 TYPE 2 DIABETES MELLITUS 97 0.0029
925 ADVERSE DRUG REACTION 254 0.0028
926 LUNG NEOPLASM MALIGNANT 114 0.0028
927 COMA 131 0.0027
928 AGGRESSION 137 0.0027
929 EYE IRRITATION 156 0.0027
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 482 0.0027
931 THERAPEUTIC RESPONSE SHORTENED 87 0.0026
932 OCULAR HYPERAEMIA 124 0.0026
933 COVID-19 453 0.0026
934 OSTEONECROSIS 84 0.0026
935 UNEVALUABLE EVENT 191 0.0025
936 THERAPY CESSATION 128 0.0025
937 CARDIAC DISORDER 228 0.0024
938 HEAD INJURY 77 0.0024
939 DIABETIC KETOACIDOSIS 58 0.0024
940 IRRITABILITY 144 0.0024
941 PSORIATIC ARTHROPATHY 96 0.0024
942 EYE PRURITUS 79 0.0023
943 NEOPLASM PROGRESSION 81 0.0023
944 PLASMA CELL MYELOMA 88 0.0023
945 RHEUMATOID ARTHRITIS 254 0.0022
946 FEMUR FRACTURE 69 0.0022
947 MALIGNANT NEOPLASM PROGRESSION 226 0.0022
948 INTENTIONAL PRODUCT MISUSE 190 0.0022
949 FLUSHING 219 0.0022
950 ROAD TRAFFIC ACCIDENT 89 0.0021
951 VAGINAL HAEMORRHAGE 89 0.0020
952 SUICIDE ATTEMPT 124 0.0020
953 ANGER 69 0.0020
954 DRY SKIN 268 0.0020
955 DRUG ABUSE 162 0.0019
956 COMPLETED SUICIDE 162 0.0019
957 MYOCARDIAL INFARCTION 335 0.0019
958 PRODUCT DOSE OMISSION 122 0.0019
959 OVERDOSE 399 0.0018
960 HOSPITALISATION 276 0.0018
961 MYELOSUPPRESSION 64 0.0018
962 BLOOD GLUCOSE DECREASED 83 0.0017
963 MATERNAL EXPOSURE DURING PREGNANCY 154 0.0017
964 CEREBROVASCULAR ACCIDENT 292 0.0017
965 SURGERY 100 0.0017
966 ADVERSE EVENT 153 0.0017
967 NEOPLASM MALIGNANT 110 0.0016
968 DEATH 1404 0.0016
969 PRODUCT DOSE OMISSION ISSUE 466 0.0016
970 FOETAL EXPOSURE DURING PREGNANCY 125 0.0015
971 BLOOD GLUCOSE INCREASED 289 0.0015
972 THERAPEUTIC RESPONSE DECREASED 91 0.0015
973 ACNE 111 0.0015
974 MULTIPLE SCLEROSIS 64 0.0013
975 INTENTIONAL OVERDOSE 85 0.0013
976 INCORRECT DOSE ADMINISTERED 285 0.0012
977 SKIN IRRITATION 57 0.0012
978 THERAPY INTERRUPTED 88 0.0012
979 MULTIPLE SCLEROSIS RELAPSE 84 0.0012
980 PSORIASIS 159 0.0012
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
982 UNDERDOSE 81 0.0011
983 DRUG WITHDRAWAL SYNDROME 84 0.0010
984 DRUG DOSE OMISSION 156 0.0009
985 INJECTION SITE PRURITUS 58 0.0009
986 NO ADVERSE EVENT 150 0.0008
987 DRUG DEPENDENCE 131 0.0008
988 INJECTION SITE SWELLING 62 0.0008
989 PROSTATE CANCER 61 0.0008
990 INJECTION SITE ERYTHEMA 88 0.0007
991 INJECTION SITE PAIN 196 0.0006
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 128 0.0006
993 PRODUCT QUALITY ISSUE 81 0.0006